Kymera Therapeutics, Inc. (KYMR)
119.21
+0.40
(+0.34%)
USD |
NASDAQ |
Sep 01, 16:00
119.21
0.00 (0.00%)
After-Hours: 19:30
Kymera Therapeutics Free Cash Flow : -237.96M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -237.96M |
| March 31, 2026 | -244.00M |
| December 31, 2025 | -234.34M |
| September 30, 2025 | -230.21M |
| June 30, 2025 | -252.92M |
| March 31, 2025 | -239.96M |
| December 31, 2024 | -207.34M |
| September 30, 2024 | -148.20M |
| June 30, 2024 | -137.92M |
| March 31, 2024 | -136.32M |
| December 31, 2023 | -137.31M |
| September 30, 2023 | -173.64M |
| Date | Value |
|---|---|
| June 30, 2023 | -169.42M |
| March 31, 2023 | -163.12M |
| December 31, 2022 | -155.92M |
| September 30, 2022 | -154.86M |
| June 30, 2022 | -156.92M |
| March 31, 2022 | -148.33M |
| December 31, 2021 | -130.54M |
| September 30, 2021 | -113.20M |
| June 30, 2021 | 53.63M |
| March 31, 2021 | 69.50M |
| December 31, 2020 | 79.03M |
| September 30, 2020 | 89.54M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -75.11M |
| Oncolytics Biotech, Inc. | -26.53M |
| Sangamo Therapeutics, Inc. | -90.46M |
| Sarepta Therapeutics, Inc. | 58.34M |
| Anixa Biosciences, Inc. | -7.117M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -54.06M |
| Cash from Investing (Quarterly) | 20.04M |
| Cash from Financing (Quarterly) | 14.42M |
| Free Cash Flow Per Share (Quarterly) | -0.5555 |
| Free Cash Flow to Equity (Quarterly) | -52.63M |
| Free Cash Flow to Firm (Quarterly) | -54.46M |
| Free Cash Flow Yield | -2.14% |